As IntraBio works to grow the global treatment market for Aqneursa in Niemann-Pick disease type C, the company is already ...

What started as occasional stomachaches and migraines for Valerie Kraft throughout her childhood turned into a decade-long ...

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...

IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA® (levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...

Huntington's disease is caused by an inherited genetic change that causes production of an altered protein. This leads to nerve damage in areas of the brain that control movement and thinking.

Brain development does not end at 25 but continues into the early 30s as neural networks become more efficient and ...

Symptoms caused by Huntington's disease include loss of motor control, involuntary movements, dementia, mood disorders, and psychiatric though disturbances.

Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...

Allison Herries, RDN, is a registered dietitian for a telehealth company. In her role, she provides nutrition education and counseling to help her clients set and reach their personal health goals.